<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-pathogens-08-00176">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Vita</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Quartuccio</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Isola</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mazzaro</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Scaini</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lenzi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Campanini</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Naclerio</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Tavoni</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pietrogrande</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis</article-title>
  <source>Arthritis Rheum.</source>
  <year>2012</year>
  <volume>64</volume>
  <fpage>843</fpage>
  <lpage>853</lpage>
  <pub-id pub-id-type="doi">10.1002/art.34331</pub-id>
  <?supplied-pmid 22147661?>
  <pub-id pub-id-type="pmid">22147661</pub-id>
 </element-citation>
</ref>
